Comments
Loading...
Dyne Therapeutics Insider Trading Activity | NASDAQ:DYN | Benzinga
Track the latest Dyne Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Dyne Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Dyne Therapeutics Inc Insiders Doing?
At Dyne Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 13.65K shares worth $165.48K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 13, 2025, Johanna FriedlNaderer, the company's CHIEF COMMERCIAL OFFICER sold 143 shares for $12.12 each.
- On March 7, 2025, Richard Scalzo, the company's SVP, HEAD FINANCE & ADMIN. sold 917 shares for $11.83 each.
- On March 7, 2025, Oxana Beskrovnaya, the company's CHIEF SCIENTIFIC OFFICER sold 1.09K shares for $11.83 each.
Ownership Statistics for Dyne Therapeutics Inc
Shares Outstanding
113.121M
Insider Shares Owned
2.357M
Insider Percentage Owned
2.08%
Institutional Shares Held
48.194M
Institutional Percentage Held
42.6%
| Mar 13, 2025 | Johanna FriedlNaderer | CHIEF COMMERCIAL OFFICER | -143.00 | $12.12 | -$1.73K | SELL | -0.15% | 96.06K | Mar 13 | View |
| Mar 13, 2025 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -1.34K | $11.38 | -$15.28K | SELL | -1.09% | 122.33K | Mar 11 | View |
| Mar 13, 2025 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.15K | $11.38 | -$24.50K | SELL | -1.09% | 195.84K | Mar 11 | View |
| Mar 07, 2025 | Douglas Kerr | CHIEF MEDICAL OFFICER | -1.34K | $11.83 | -$15.89K | SELL | -1.41% | 94.16K | Mar 05 | View |
| Mar 07, 2025 | John Cox | CEO & PRESIDENT | -4.06K | $11.83 | -$48.04K | SELL | -2.57% | 154.24K | Mar 05 | View |
| Mar 07, 2025 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -917.00 | $11.83 | -$10.85K | SELL | -0.74% | 123.67K | Mar 05 | View |
| Mar 07, 2025 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.09K | $11.83 | -$12.94K | SELL | -0.55% | 197.99K | Mar 05 | View |
| Feb 25, 2025 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.60K | $13.95 | -$36.24K | SELL | -1.29% | 199.09K | Feb 18 | View |
| Feb 18, 2025 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.49K | $13.95 | -$34.71K | SELL | -1.96% | 124.59K | Feb 18 | View |
| Dec 11, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.33K | $28.12 | -$65.63K | SELL | -1.14% | 201.69K | Dec 11 | View |
| Dec 11, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -1.46K | $28.12 | -$40.91K | SELL | -1.13% | 127.08K | Dec 11 | View |
| Dec 10, 2024 | Dirk Kersten | — | -136.11K | $29.30 | -$3.99M | SELL | -2.43% | 5.46M | Dec 06 - Dec 09 | View |
| Dec 06, 2024 | Dirk Kersten | — | -138.84K | $29.38 | -$4.08M | SELL | -2.42% | 5.60M | Dec 04 - Dec 05 | View |
| Dec 04, 2024 | Dirk Kersten | — | -110.93K | $29.50 | -$3.27M | SELL | -1.90% | 5.74M | Dec 02 - Dec 03 | View |
| Nov 18, 2024 | Carlo Incerti | — | 0.00 | $18.71 | -$330.66K | SELL-OPTIONS | 0.00% | 0.00 | Nov 18 | View |
| Nov 18, 2024 | Jason Rhodes | — | -782.00 | $33.10 | -$25.88K | SELL | -0.09% | 847.32K | Nov 14 | View |
| Nov 18, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.73K | $28.20 | -$77.13K | SELL | -2.77% | 95.83K | Nov 18 | View |
| Nov 18, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.86K | $28.20 | -$80.54K | SELL | -2.03% | 137.52K | Nov 18 | View |
| Nov 15, 2024 | Dirk Kersten | — | -19.73K | $34.14 | -$673.75K | SELL | -0.34% | 5.79M | Nov 13 - Nov 14 | View |
| Oct 22, 2024 | Dirk Kersten | — | -13.54K | $35.16 | -$475.88K | SELL | -0.23% | 5.87M | Oct 18 - Oct 21 | View |
| Oct 18, 2024 | Dirk Kersten | — | -36.68K | $35.29 | -$1.29M | SELL | -0.62% | 5.88M | Oct 16 - Oct 17 | View |
| Oct 07, 2024 | Dirk Kersten | — | -5.44K | $35.13 | -$191.14K | SELL | -0.09% | 5.92M | Oct 03 | View |
| Oct 03, 2024 | Dirk Kersten | — | -29.94K | $35.32 | -$1.06M | SELL | -0.50% | 5.92M | Oct 01 - Oct 02 | View |
| Oct 01, 2024 | Dirk Kersten | — | -30.97K | $35.50 | -$1.10M | SELL | -0.52% | 5.95M | Sep 27 - Sep 30 | View |
| Sep 27, 2024 | Dirk Kersten | — | -3.62K | $35.14 | -$127.10K | SELL | -0.06% | 5.99M | Sep 25 - Sep 26 | View |
| Sep 24, 2024 | Dirk Kersten | — | -120.24K | $36.07 | -$4.34M | SELL | -1.97% | 5.99M | Sep 20 - Sep 23 | View |
| Sep 20, 2024 | Dirk Kersten | — | -80.29K | $36.15 | -$2.90M | SELL | -1.30% | 6.11M | Sep 18 - Sep 19 | View |
| Sep 19, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -8.98K | $34.41 | -$308.86K | SELL | -6.38% | 131.64K | Sep 18 | View |
| Sep 19, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -1.39K | $34.55 | -$48.02K | SELL | -1.39% | 98.57K | Sep 18 | View |
| Sep 19, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.34K | $34.55 | -$80.81K | SELL | -1.64% | 140.38K | Sep 18 | View |
| Sep 18, 2024 | Dirk Kersten | — | -4.59K | $35.10 | -$161.20K | SELL | -0.07% | 6.19M | Sep 16 - Sep 17 | View |
| Sep 11, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.16K | $31.89 | -$68.91K | SELL | -1.49% | 142.71K | Sep 11 | View |
| Sep 11, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -1.47K | $31.89 | -$46.81K | SELL | -1.45% | 99.96K | Sep 11 | View |
| Sep 11, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -5.27K | $31.89 | -$168.06K | SELL | -3.61% | 140.61K | Sep 11 | View |
| Sep 10, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -9.60K | $22.36 | -$2.59M | SELL | -8.64% | 101.43K | Sep 06 | View |
| Sep 09, 2024 | Dirk Kersten | — | -1.58K | $35.03 | -$55.24K | SELL | -0.03% | 6.19M | Sep 05 | View |
| Sep 04, 2024 | John Cox | CEO & PRESIDENT | 32.00K | $33.04 | $1.06M | BUY | ∞ | 13.00K | Sep 04 | View |
| Sep 04, 2024 | Dirk Kersten | — | -31.30K | $45.59 | -$1.43M | SELL | -0.50% | 6.20M | Aug 30 | View |
| Aug 30, 2024 | Dirk Kersten | — | -134.26K | $45.03 | -$6.05M | SELL | -2.11% | 6.23M | Aug 28 - Aug 29 | View |
| Aug 28, 2024 | Dirk Kersten | — | -154.90K | $44.87 | -$6.95M | SELL | -2.38% | 6.36M | Aug 26 - Aug 27 | View |
| Aug 26, 2024 | Dirk Kersten | — | -180.41K | $46.02 | -$8.30M | SELL | -2.69% | 6.52M | Aug 22 - Aug 23 | View |
| Aug 22, 2024 | Dirk Kersten | — | -222.60K | $46.61 | -$10.38M | SELL | -3.22% | 6.70M | Aug 20 - Aug 21 | View |
| Aug 20, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.75K | $45.12 | -$124.17K | SELL | -2.42% | 111.02K | Aug 19 | View |
| Aug 20, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -2.71K | $45.12 | -$122.05K | SELL | -2.01% | 132.11K | Aug 19 | View |
| Aug 20, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -2.32K | $45.12 | -$104.73K | SELL | -1.59% | 143.22K | Aug 19 | View |
| Aug 20, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -2.91K | $45.12 | -$131.30K | SELL | -1.96% | 145.88K | Aug 19 | View |
| Aug 20, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.64K | $45.12 | -$118.94K | SELL | -1.79% | 144.88K | Aug 19 | View |
| Aug 20, 2024 | Dirk Kersten | — | -248.68K | $45.48 | -$11.31M | SELL | -3.47% | 6.92M | Aug 16 - Aug 19 | View |
| Aug 16, 2024 | Dirk Kersten | — | -281.54K | $44.76 | -$12.60M | SELL | -3.78% | 7.17M | Aug 14 - Aug 15 | View |
| Aug 14, 2024 | Dirk Kersten | — | -212.48K | $42.93 | -$9.12M | SELL | -2.77% | 7.45M | Aug 12 - Aug 13 | View |
| Aug 12, 2024 | Dirk Kersten | — | -183.83K | $42.85 | -$7.88M | SELL | -2.34% | 7.66M | Aug 08 - Aug 09 | View |
| Jun 24, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | 0.00 | $20.32 | -$1.18M | SELL-OPTIONS | 0.00% | 148.79K | Jun 21 - Jun 24 | View |
| Jun 13, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | 0.00 | $19.45 | -$1.11M | SELL-OPTIONS | 0.00% | 148.79K | Jun 12 | View |
| Jun 11, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.14K | $31.34 | -$66.94K | SELL | -1.43% | 147.51K | Jun 11 | View |
| Jun 11, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -2.64K | $31.27 | -$82.43K | SELL | -1.78% | 145.54K | Jun 11 | View |
| Jun 11, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -5.27K | $17.92 | -$2.14M | SELL | -3.42% | 148.79K | Jun 10 - Jun 11 | View |
| Jun 11, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -1.82K | $31.34 | -$57.13K | SELL | -1.33% | 134.81K | Jun 11 | View |
| Jun 11, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.92K | $30.74 | -$89.78K | SELL | -2.50% | 113.77K | Jun 10 - Jun 11 | View |
| May 22, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.99 | -$971.41K | SELL-OPTIONS | 0.00% | 149.65K | May 20 | View |
| May 17, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.71K | $28.27 | -$76.47K | SELL | -1.78% | 149.65K | May 16 | View |
| May 17, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -2.38K | $28.27 | -$67.31K | SELL | -1.58% | 148.18K | May 16 | View |
| May 17, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -2.74K | $28.27 | -$77.40K | SELL | -1.75% | 154.06K | May 16 | View |
| May 17, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.59K | $28.27 | -$73.16K | SELL | -2.17% | 116.69K | May 16 | View |
| May 17, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -2.77K | $28.27 | -$78.42K | SELL | -1.99% | 136.63K | May 16 | View |
| Mar 13, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -29.49K | $26.59 | -$784.25K | SELL | -15.83% | 156.80K | Mar 08 - Mar 11 | View |
| Mar 13, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -1.78K | $15.82 | -$2.26M | SELL | -1.26% | 139.41K | Mar 08 - Mar 11 | View |
| Mar 12, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -2.62K | $25.65 | -$67.08K | SELL | -1.71% | 150.56K | Mar 11 - Mar 12 | View |
| Mar 12, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.67K | $15.87 | -$1.85M | SELL | -2.19% | 119.28K | Mar 08 - Mar 11 | View |
| Mar 12, 2024 | Joshua Brumm | CEO & PRESIDENT | -16.39K | $15.72 | -$8.84M | SELL | -2.96% | 538.00K | Mar 08 - Mar 11 | View |
| Mar 12, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.08K | $25.70 | -$53.48K | SELL | -1.35% | 152.35K | Mar 11 | View |
| Mar 11, 2024 | Joshua Brumm | CEO & PRESIDENT | -9.09K | $25.85 | -$234.87K | SELL | -1.61% | 554.38K | Mar 07 | View |
| Mar 11, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -2.37K | $25.85 | -$61.34K | SELL | -1.51% | 154.43K | Mar 07 | View |
| Mar 11, 2024 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -1.59K | $25.85 | -$41.13K | SELL | -0.85% | 186.29K | Mar 07 | View |
| Mar 11, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -9.92K | $25.86 | -$256.58K | SELL | -6.08% | 153.18K | Mar 07 | View |
| Mar 11, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -2.43K | $25.85 | -$62.92K | SELL | -1.69% | 141.18K | Mar 07 | View |
| Mar 11, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | -2.27K | $25.85 | -$58.76K | SELL | -1.83% | 121.95K | Mar 07 | View |
| Mar 05, 2024 | Jason Rhodes | — | -46.53K | $30.05 | -$1.40M | SELL | -0.71% | 6.55M | Mar 01 | View |
| Mar 05, 2024 | Atlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -46.53K | $30.05 | -$1.40M | SELL | -5.21% | 847.39K | Mar 01 | View |
| Mar 01, 2024 | Joshua Brumm | CEO & PRESIDENT | 0.00 | $17.25 | -$2.34M | SELL-OPTIONS | 0.00% | 563.47K | Feb 29 - Mar 01 | View |
| Mar 01, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | 0.00 | $14.59 | -$791.04K | SELL-OPTIONS | 0.00% | 143.62K | Feb 29 - Mar 01 | View |
| Mar 01, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | 0.00 | $14.54 | -$344.17K | SELL-OPTIONS | 0.00% | 124.23K | Feb 29 - Mar 01 | View |
| Feb 28, 2024 | Jason Rhodes | — | -807.84K | $24.30 | -$19.63M | SELL | -48.31% | 864.49K | Feb 26 - Feb 28 | View |
| Feb 28, 2024 | Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -807.84K | $24.30 | -$19.63M | SELL | -48.31% | 864.49K | Feb 26 - Feb 28 | View |
| Feb 28, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -407.00 | $25.00 | -$10.18K | SELL | -0.25% | 163.10K | Feb 28 | View |
| Feb 23, 2024 | Jason Rhodes | — | -500.79K | $22.64 | -$11.34M | SELL | -35.23% | 920.84K | Feb 21 - Feb 23 | View |
| Feb 23, 2024 | Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -500.79K | $22.64 | -$11.34M | SELL | -35.23% | 920.84K | Feb 21 - Feb 23 | View |
| Feb 20, 2024 | Jason Rhodes | — | -510.15K | $23.26 | -$11.87M | SELL | -6.18% | 7.75M | Feb 15 - Feb 20 | View |
| Feb 20, 2024 | Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLC | 10% OWNER | -510.15K | $23.26 | -$11.87M | SELL | -6.96% | 6.82M | Feb 15 - Feb 20 | View |
| Feb 14, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -5.49K | $25.07 | -$137.71K | SELL | -3.25% | 163.50K | Feb 12 | View |
| Jan 26, 2024 | Wildon Farwell | CHIEF MEDICAL OFFICER | -100.00 | $25.00 | -$2.50K | SELL | -0.06% | 169.00K | Jan 26 | View |
| Jan 26, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | 0.00 | $12.63 | -$475.91K | SELL-OPTIONS | 0.00% | 143.62K | Jan 26 | View |
| Jan 26, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | 0.00 | $12.69 | -$303.03K | SELL-OPTIONS | 0.00% | 124.23K | Jan 26 | View |
| Jan 11, 2024 | Dirk Kersten | — | 1.71M | $17.50 | $30.00M | BUY | ∞ | 1.43M | Jan 09 | View |
| Jan 04, 2024 | Joshua Brumm | CEO & PRESIDENT | 0.00 | $11.52 | -$3.85M | SELL-OPTIONS | 0.00% | 584.97K | Jan 03 - Jan 04 | View |
| Jan 04, 2024 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -19.78K | $9.80 | -$1.56M | SELL | -11.20% | 156.81K | Jan 03 - Jan 04 | View |
| Jan 04, 2024 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -11.90K | $8.66 | -$514.59K | SELL | -7.65% | 143.62K | Jan 02 - Jan 04 | View |
| Jan 04, 2024 | Richard Scalzo | SVP, HEAD FINANCE & ADMIN. | 0.00 | $9.92 | -$231.14K | SELL-OPTIONS | 0.00% | 124.23K | Jan 03 | View |
| Dec 14, 2023 | Richard Scalzo | SEE REMARKS | -2.38K | $12.02 | -$28.56K | SELL | -1.88% | 124.23K | Dec 14 | View |
| Dec 12, 2023 | Richard Scalzo | SEE REMARKS | -1.38K | $10.72 | -$14.79K | SELL | -1.08% | 126.60K | Dec 11 | View |
| Dec 12, 2023 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -1.25K | $10.72 | -$13.35K | SELL | -0.79% | 155.52K | Dec 11 | View |
| Dec 12, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -1.62K | $10.72 | -$17.32K | SELL | -0.85% | 187.88K | Dec 11 | View |
| Dec 12, 2023 | Wildon Farwell | CHIEF MEDICAL OFFICER | -2.67K | $10.66 | -$28.41K | SELL | -1.55% | 169.10K | Dec 11 - Dec 12 | View |
| Dec 12, 2023 | Joshua Brumm | SEE REMARKS | -7.58K | $10.72 | -$81.31K | SELL | -1.28% | 584.97K | Dec 11 | View |
| Dec 12, 2023 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.47K | $10.72 | -$15.73K | SELL | -0.82% | 176.59K | Dec 11 | View |
| Dec 06, 2023 | Richard Scalzo | SEE REMARKS | -2.55K | $12.01 | -$30.66K | SELL | -1.96% | 127.98K | Dec 04 - Dec 06 | View |
| Nov 02, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -9.94K | $7.40 | -$73.55K | SELL | -9.51% | 94.61K | Nov 02 | View |
| Sep 20, 2023 | Richard Scalzo | SEE REMARKS | -1.29K | $9.41 | -$12.14K | SELL | -3.07% | 40.80K | Sep 18 | View |
| Sep 20, 2023 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -1.26K | $9.41 | -$11.87K | SELL | -2.04% | 60.60K | Sep 18 | View |
| Sep 20, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -2.67K | $9.41 | -$25.14K | SELL | -2.49% | 104.54K | Sep 18 | View |
| Sep 20, 2023 | Joshua Brumm | SEE REMARKS | -12.03K | $9.41 | -$113.22K | SELL | -4.90% | 233.68K | Sep 18 | View |
| Sep 20, 2023 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.44K | $9.41 | -$13.51K | SELL | -1.67% | 84.33K | Sep 18 | View |
| Sep 13, 2023 | Wildon Farwell | CHIEF MEDICAL OFFICER | -1.71K | $10.41 | -$17.77K | SELL | -1.88% | 89.25K | Sep 12 | View |
| Sep 13, 2023 | Richard Scalzo | SEE REMARKS | -1.40K | $10.41 | -$14.54K | SELL | -3.21% | 42.09K | Sep 12 | View |
| Sep 13, 2023 | Jonathan McNeill | CHIEF BUSINESS OFFICER | -1.27K | $10.41 | -$13.18K | SELL | -2.01% | 61.87K | Sep 12 | View |
| Sep 13, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -1.64K | $10.41 | -$17.02K | SELL | -1.50% | 107.22K | Sep 12 | View |
| Sep 13, 2023 | Joshua Brumm | SEE REMARKS | -7.67K | $10.41 | -$79.87K | SELL | -3.03% | 245.71K | Sep 12 | View |
| Sep 13, 2023 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.48K | $10.41 | -$15.45K | SELL | -1.70% | 85.77K | Sep 12 | View |
| Jun 15, 2023 | Richard Scalzo | SEE REMARKS | -11.39K | $6.87 | -$611.98K | SELL | -20.76% | 43.48K | Jun 13 - Jun 15 | View |
| Jun 14, 2023 | Jonathan McNeill | SEE REMARKS | -2.26K | $12.68 | -$28.65K | SELL | -3.45% | 63.13K | Jun 12 - Jun 13 | View |
| Jun 14, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -1.63K | $12.43 | -$20.20K | SELL | -1.47% | 108.85K | Jun 13 | View |
| Jun 14, 2023 | Wildon Farwell | CHIEF MEDICAL OFFICER | -1.70K | $12.43 | -$21.11K | SELL | -1.83% | 90.96K | Jun 13 | View |
| Jun 14, 2023 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.48K | $12.43 | -$18.33K | SELL | -1.66% | 87.25K | Jun 13 | View |
| Jun 12, 2023 | Joshua Brumm | SEE REMARKS | -69.10K | $6.96 | -$3.91M | SELL | -21.43% | 253.38K | Jun 08 - Jun 12 | View |
| Mar 15, 2023 | Richard Scalzo | SEE REMARKS | -1.31K | $13.33 | -$17.48K | SELL | -2.33% | 54.87K | Mar 14 | View |
| Mar 15, 2023 | Jonathan McNeill | SEE REMARKS | -2.21K | $13.18 | -$29.12K | SELL | -3.27% | 65.39K | Mar 13 - Mar 14 | View |
| Mar 15, 2023 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -1.56K | $13.33 | -$20.78K | SELL | -1.39% | 110.48K | Mar 14 | View |
| Mar 15, 2023 | Wildon Farwell | CHIEF MEDICAL OFFICER | -7.44K | $13.33 | -$99.19K | SELL | -7.43% | 92.66K | Mar 14 | View |
| Mar 15, 2023 | Joshua Brumm | SEE REMARKS | -7.32K | $13.33 | -$97.55K | SELL | -2.22% | 322.48K | Mar 14 | View |
| Mar 15, 2023 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.42K | $13.33 | -$18.88K | SELL | -1.57% | 88.73K | Mar 14 | View |
| Jan 23, 2023 | Jonathan McNeill | SEE REMARKS | 0.00 | $7.38 | -$133.00K | SELL-OPTIONS | 0.00% | 67.60K | Jan 18 | View |
| Jan 11, 2023 | Jonathan McNeill | SEE REMARKS | -30.15K | $11.57 | -$348.84K | SELL | -30.84% | 67.60K | Jan 09 | View |
| Dec 14, 2022 | Jason Rhodes | DIRECTOR | 934.58K | $10.70 | $10.00M | BUY | 58.09% | 2.54M | Dec 12 | View |
| Dec 14, 2022 | Atlas Venture Opportunity Fund II LPAtlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | 934.58K | $10.70 | $10.00M | BUY | 58.09% | 2.54M | Dec 12 | View |
| Dec 13, 2022 | Richard Scalzo | SEE REMARKS | 30.69K | $10.87 | -$3.39K | GRANT | 120.37% | 56.18K | Dec 09 - Dec 12 | View |
| Dec 13, 2022 | Jonathan McNeill | SEE REMARKS | 39.53K | $10.87 | -$5.13K | GRANT | 67.89% | 97.75K | Dec 09 - Dec 12 | View |
| Dec 13, 2022 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | 43.25K | $10.87 | -$8.16K | GRANT | 62.87% | 112.03K | Dec 09 - Dec 12 | View |
| Dec 13, 2022 | Wildon Farwell | CHIEF MEDICAL OFFICER | 35.37K | $10.87 | -$6.83K | GRANT | 54.65% | 100.10K | Dec 09 - Dec 12 | View |
| Dec 13, 2022 | Joshua Brumm | SEE REMARKS | 140.68K | $10.87 | -$36.11K | GRANT | 74.38% | 329.80K | Dec 09 - Dec 12 | View |
| Dec 13, 2022 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | 39.32K | $10.87 | -$7.39K | GRANT | 77.36% | 90.14K | Dec 09 - Dec 12 | View |
| Oct 11, 2022 | Joshua Brumm | SEE REMARKS | -15.50K | $6.78 | -$2.41M | SELL | -7.57% | 189.12K | Oct 07 - Oct 10 | View |
| Mar 14, 2022 | Richard Scalzo | SEE REMARKS | -308.00 | $8.73 | -$2.69K | SELL | -1.13% | 26.99K | Mar 11 | View |
| Mar 14, 2022 | Jonathan McNeill | SEE REMARKS | -481.00 | $8.73 | -$4.20K | SELL | -0.79% | 60.47K | Mar 11 | View |
| Mar 14, 2022 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -765.00 | $8.73 | -$6.68K | SELL | -1.04% | 73.00K | Mar 11 | View |
| Mar 14, 2022 | Wildon Farwell | CHIEF MEDICAL OFFICER | -640.00 | $8.73 | -$5.59K | SELL | -0.96% | 66.05K | Mar 11 | View |
| Mar 14, 2022 | Joshua Brumm | SEE REMARKS | -3.38K | $8.73 | -$29.54K | SELL | -1.58% | 210.32K | Mar 11 | View |
| Mar 14, 2022 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -693.00 | $8.73 | -$6.05K | SELL | -1.27% | 53.68K | Mar 11 | View |
| Mar 03, 2022 | Wildon Farwell | CHIEF MEDICAL OFFICER | -5.62K | $8.56 | -$48.08K | SELL | -7.77% | 66.69K | Mar 02 | View |
| Sep 24, 2021 | GATTI SUSANNA HIGH | CHIEF OPERATING OFFICER | -2.45K | $17.22 | -$42.21K | SELL | -6.83% | 33.45K | Sep 23 | View |
| Sep 22, 2021 | Richard Scalzo Attorney-in-Fact | SEE REMARKS | -859.00 | $15.90 | -$13.65K | SELL | -7.49% | 10.61K | Sep 20 - Sep 21 | View |
| Sep 22, 2021 | Jonathan McNeill | SEE REMARKS | -1.27K | $15.90 | -$20.25K | SELL | -3.45% | 35.64K | Sep 20 - Sep 21 | View |
| Sep 22, 2021 | Joshua Brumm | SEE REMARKS | -8.01K | $15.90 | -$127.31K | SELL | -7.48% | 99.02K | Sep 20 - Sep 21 | View |
| Sep 22, 2021 | Oxana Beskrovnaya | CHIEF SCIENTIFIC OFFICER | -1.44K | $15.90 | -$22.95K | SELL | -7.49% | 17.84K | Sep 20 - Sep 21 | View |
| Sep 23, 2020 | VV Manager II LLCVida Ventures II LLCVIDA VENTURES IIA LLC | — | 2.96M | $19.00 | $15.48M | DERIVATIVE CONVERSION | ∞ | 79.92K | Sep 21 | View |
| Sep 23, 2020 | Logos Global Management LP | — | 1.50M | $19.00 | $13.30M | DERIVATIVE CONVERSION | ∞ | 1.50M | Sep 21 | View |
| Sep 23, 2020 | RA CAPITAL MANAGEMENT LPPeter KolchinskyRajeev Shah | — | 2.81M | $19.00 | $12.54M | DERIVATIVE CONVERSION | ∞ | 2.81M | Sep 21 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.